Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide
- 1 April 2009
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 296 (4) , F790-F794
Abstract
Thromboxane (TxA2) and nitric oxide (NO) are potent vasoactive autocoids that modulate tubuloglomerular feedback (TGF). Each is produced in the macula densa (MD) by cyclooxygenase-2 (COX-2) and neuronal nitric oxide synthase (nNOS), respectively. Both enzymes are similarly regulated in the MD and their interaction may be an important factor in the regulation of TGF and glomerular filtration rate. We tested the hypothesis that TGF is modified by the balance between MD nNOS-dependent NO and MD COX-2-dependent TxA2. We measured maximal TGF during perfusion of the loop of Henle (LH) by continuous recording of the proximal tubule stopped flow pressure response to LH perfusion of artificial tubular fluid (ATF) at 0 and 40 nl/min. The response to inhibitors of COX-1 (SC-560), COX-2 [parecoxib (Pxb)], and nNOS (l-NPA) added to the ATF solution was measured in separate nephrons. COX-2 inhibition with Pxb reduced TGF by 46% (ATF + vehicle vs. ATF + Pxb), whereas COX-1 inhibition with SC-560 reduced TGF by only 23%. Pretreatment with intravenous infusion of SQ-29,548, a selective thromboxone/PGH2 receptor (TPR) antagonist, blocked all of the SC-560 effect on TGF, suggesting that this effect was due to activation of TPR. However, SQ-29,548 only partially diminished the effect of Pxb (−66%). Specific inhibition of nNOS with l-NPA increased TGF, as expected. However, the ability of Pxb to reduce TGF was significantly impaired with comicroperfusion of l-NPA. These data suggest that COX-2 modulates TGF by two proconstrictive actions: generation of TxA2 acting on TPR and by simultaneous reduction of NO.Keywords
This publication has 47 references indexed in Scilit:
- Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cellsToxicology, 2008
- Cyclooxygenase-2-dependent neuronal death proceeds via superoxide anion generationFree Radical Biology and Medicine, 2006
- Differentiation of Cyclooxygenase 1- and 2–Derived Prostanoids in Mouse Kidney and AortaHypertension, 2006
- COX-2 and the KidneyJournal of Cardiovascular Pharmacology, 2006
- Effect of Tempol on Renal Cyclooxygenase Expression and Activity in Experimental Diabetes in the RatThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Cyclooxygenase-2 Inhibition Improves Vascular Endothelial Dysfunction in a Rat Model of Endotoxic Shock: Role of Inducible Nitric-Oxide Synthase and Oxidative StressThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Upregulation of macula densa cyclooxygenase-2 expression is not dependent on glomerular filtrationAmerican Journal of Physiology-Renal Physiology, 2004
- Epithelial COX-2 Expression Is Not Regulated By Nitric Oxide in Rodent Renal CortexHypertension, 2002
- Vasoconstrictor responses in thromboxane receptor knockout mice: tubuloglomerular feedback and ureteral obstructionActa Physiologica Scandinavica, 2000
- Thromboxane receptors in human kidney tissuesProstaglandins & Other Lipid Mediators, 1999